These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6278193)

  • 1. Tumor promoter 12-O-tetradecanoylphorbol 13-acetate: effect on complement and Epstein-Barr virus receptors in human lymphoblastoid cell lines.
    Yamamoto N; Mitsuma T; Vogt A
    J Natl Cancer Inst; 1982 Mar; 68(3):385-90. PubMed ID: 6278193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of human malignant T-lymphoblastic cell lines MOLT-3 and jurkat by 12-O-tetradecanoylphorbol-13-acetate: biochemical, physical, and morphological characterization.
    Nagasawa K; Howatson A; Mak TW
    J Cell Physiol; 1981 Oct; 109(1):181-92. PubMed ID: 6976970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between tumor promoter binding and Epstein-Barr virus induction in human lymphoblastoid cell lines.
    Yamamoto N; Bauer G
    J Cell Physiol; 1981 Dec; 109(3):397-402. PubMed ID: 6274878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epstein-Barr virus receptor is distinct from the C3 receptor.
    Wells A; Koide N; Stein H; Gerdes J; Klein G
    J Gen Virol; 1983 Feb; 64 (Pt 2)():449-53. PubMed ID: 6300295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phorbol ester-induced expression and function of the interleukin 2 receptor in human B lymphocytes.
    Ando I; Crawford DH; Kissonerghis MA; Owen MJ; Beverley PC
    Eur J Immunol; 1985 Apr; 15(4):341-4. PubMed ID: 2985401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers.
    Zeuthen J; Klein G; Ber R; Masucci G; Bisballe S; Povey S; Terasaki P; Ralph P
    J Natl Cancer Inst; 1982 Feb; 68(2):179-95. PubMed ID: 6278187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers.
    Magrath IT; Freeman CB; Pizzo P; Gadek J; Jaffe E; Santaella M; Hammer C; Frank M; Reaman G; Novikovs L
    J Natl Cancer Inst; 1980 Mar; 64(3):477-83. PubMed ID: 6243722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phorbol ester enhances both interleukin 2 receptor expression and immunoglobulin secretion in human Epstein-Barr virus-immortalized B cells.
    Polke CR; Lowenthal JW; Roth SA; Rohwer P; MacDonald HR; Kalden JR
    Eur J Immunol; 1986 Feb; 16(2):146-50. PubMed ID: 3007165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of fluoresceinated complement-coated bacteria and sheep erythrocyte-antibody-complement complexes for identification of complement receptors on lymphoid cell lines: differences in binding characteristics between cell lines of normal and malignant origin.
    Benjamin D; Magrath IT; Freeman CB
    J Natl Cancer Inst; 1983 Nov; 71(5):897-902. PubMed ID: 6316012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of indomethacin on Epstein-Barr virus early antigen induction.
    Daniel LW; Bauer G; zur Hausen H
    Cancer Res; 1984 Mar; 44(3):981-3. PubMed ID: 6318991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement receptor expression by neoplastic and normal human cells.
    Gaither TA; Magrath IT; Berger M; Hammer CH; Novikovs L; Santaella M; Frank MM
    J Immunol; 1983 Aug; 131(2):899-905. PubMed ID: 6306108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ecto-5'-nucleotidase. II. Effect of 12-O-tetradecanoylphorbol 13-acetate on the expression of enzyme in normal and neoplastic B-cell lines.
    Hibi T; SenGupta S; MacKay A; Gelfand EW; Chechik BE
    J Natl Cancer Inst; 1984 Nov; 73(5):1081-5. PubMed ID: 6092766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns.
    Klein G; Zeuthen J; Ber R; Ernberg I
    J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in SRBC binding capacity and T-surface antigen expression on human peripheral blood lymphocytes stimulated by 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Matera L; Foa R; Marmont F; Massaia M; Palumbo A; Pegoraro L
    J Clin Lab Immunol; 1983 Sep; 12(1):57-61. PubMed ID: 6688831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues.
    Takasaka N; Tajima M; Okinaga K; Satoh Y; Hoshikawa Y; Katsumoto T; Kurata T; Sairenji T
    Virology; 1998 Aug; 247(2):152-9. PubMed ID: 9705908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-promoting phorbol esters inhibit DNA synthesis and enhance virus-induced interferon production in a human lymphoma cell line.
    Adolf GR; Swetly P
    J Gen Virol; 1980 Nov; 51(Pt 1):61-7. PubMed ID: 6161998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phorbol ester-induced differentiation of human T-lymphoblastic cell line HPB-ALL.
    Nakao Y; Matsuda S; Fujita T; Watanabe S; Morikawa S; Saida T; Ito Y
    Cancer Res; 1982 Sep; 42(9):3843-50. PubMed ID: 6179612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cytotoxicity of tumour promoter TPA for EBV-negative human lymphoma cell lines and their EBV-converted sublines.
    Béchet JM; Guétard D
    Int J Cancer; 1983 Jul; 32(1):61-5. PubMed ID: 6305854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the Epstein-Barr virus receptor found on Raji cells. I. Extraction of receptor and preparation of anti-receptor antibody.
    Simmons JG; Hutt-Fletcher LM; Fowler E; Feighny RJ
    J Immunol; 1983 Mar; 130(3):1303-8. PubMed ID: 6337215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.